EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tattoos and Risk of Hematologic Cancer: A Population‐Based Case–Control Study in Utah

Rachel D McCarty iD, Britton Trabert, David Kriebel, Morgan M Millar iD, Brenda M Birmann, Laurie Grieshober, Mollie E Barnard, Lindsay J Collin iD, Katherine A Lawson-Michod iD, Brody Gibson, Jenna Sawatzki, Marjorie Carter und 4 weitere

Cancer Medicine · 2024-10 · 13 (20)

DOI: 10.1002/cam4.70260 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 23.10.2024. Verfasst von Rachel D McCarty und 15 weiteren Autor:innen. Beteiligte Einrichtung: Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Tattooing, Hematologic Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NCI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Approximately one‐third of US adults have a tattoo, and the prevalence is increasing. Tattooing can result in long‐term exposure to carcinogens and inflammatory and immune responses.

Methods

We examined tattooing and risk of hematologic cancers in a population‐based case–control study with 820 cases diagnosed 2019–2021 and 8200 frequency‐matched controls, ages 18–79 years. We calculated odds ratios (OR) and 95% confidence intervals (CI) using multivariable‐adjusted logistic regression models.

Results

The prevalence of tattooing was 22% among Hodgkin lymphoma (HL) cases, 11% among non‐Hodgkin lymphoma (NHL) cases, 16% among myeloid neoplasm cases, and 15% among controls. Though there were no clear patterns of associations between ever receiving a tattoo and risk of HL, NHL, or myeloid neoplasms overall, in analyses restricted to ages 20–60 years, ever receiving a tattoo (OR 2.06 [95% CI 1.01, 4.20]) and receiving a tattoo 10+ years prior (OR 2.64 [95% CI 1.23, 5.68]) were associated with an aggregated group of rarer mature B‐cell NHLs. We also observed elevated risks for a 10+ year latency for myelodysplastic syndromes and chronic myeloid leukemia (OR 1.48 [95% CI 0.40, 5.41], and OR 1.24 [95% CI 0.45, 3.43], respectively).

Conclusions

Though estimates were imprecise, we found some suggestive evidence that tattooing may be associated with an increased risk of certain hematologic cancer subtypes. With an estimated 46% prevalence of tattooing in US individuals ages 30–49, additional studies are needed to understand the degree to which these exposures may be associated with hematologic cancer risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TattooingHematologic NeoplasmsHumansMiddle AgedAdultCase-Control StudiesMaleFemaleAgedYoung AdultAdolescentUtahRisk FactorsPrevalenceLymphoma, Non-HodgkinHodgkin Disease

Stichwörter der Autor:innen

epidemiologyleukemialymphoid neoplasmslymphomamyeloid neoplasmstattoos

Autor:innen und Institutionen

  • Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
  • Department of Population Health Sciences Spencer Fox Eccles School of Medicine, University of Utah Intermountain Healthcare, University of Utah, Salt Lake City, Utah, USA.
  • Department of Obstetrics and Gynecology, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, Utah, USA.
  • Lowell Center for Sustainable Production, University of Massachusetts Lowell, Lowell, Massachusetts, USA.
  • Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
  • Utah Cancer Registry, University of Utah, Salt Lake City, Utah, USA.

ORCID-Profile: Rachel D McCarty, Morgan M Millar, Lindsay J Collin, Katherine A Lawson-Michod, Jennifer A Doherty

Förderung

  • NIH HHS
  • NCI NIH HHS
  • NCATS NIH HHS
  • Huntsman Cancer Institute, University of Utah
  • Huntsman Cancer Foundation
  • CDC HHS
  • National Institutes of Health
  • National Cancer Institute

Zitieren

APA

McCarty, R. D., Trabert, B., Kriebel, D., Millar, M. M., Birmann, B. M., Grieshober, L., Barnard, M. E., Collin, L. J., Lawson-Michod, K. A., Gibson, B., Sawatzki, J., Carter, M., Yoder, V., Gilreath, J. A., Shami, P. J., & Doherty, J. A. (2024). Tattoos and Risk of Hematologic Cancer: A Population‐Based Case–Control Study in Utah. Cancer Medicine, 13(20). https://doi.org/10.1002/cam4.70260

Vancouver

McCarty RD, Trabert B, Kriebel D, Millar MM, Birmann BM, Grieshober L, et al. Tattoos and Risk of Hematologic Cancer: A Population‐Based Case–Control Study in Utah. Cancer Medicine. 2024;13(20). doi:10.1002/cam4.70260

BibTeX
@article{McCarty2024,
  author = {McCarty, Rachel D and Trabert, Britton and Kriebel, David and Millar, Morgan M and Birmann, Brenda M and Grieshober, Laurie and Barnard, Mollie E and Collin, Lindsay J and Lawson-Michod, Katherine A and Gibson, Brody and Sawatzki, Jenna and Carter, Marjorie and Yoder, Valerie and Gilreath, Jeffrey A and Shami, Paul J and Doherty, Jennifer A},
  title = {Tattoos and Risk of Hematologic Cancer: A Population‐Based Case–Control Study in Utah},
  journal = {Cancer Medicine},
  year = {2024},
  volume = {13},
  number = {20},
  doi = {10.1002/cam4.70260}
}
Kostenlos starten →